Previous Post
Tweet about this on TwitterShare on TumblrPin on PinterestShare on LinkedInShare on Google+Email this to someoneShare on Facebook
Read on Mobile

John Rex

John H. Rex, MD is Senior Vice President and Chief Strategy Officer for AstraZeneca Infection, a Non-Executive Director of F2G, Ltd. and Adenium Biotech ApS, Expert-in-Residence at the Wellcome Trust, and a member of the US Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. Dr. Rex thus brings a global perspective to the challenge of AMR as well as both small and large pharmaceutical company experience. As an example, he is one of two Industry-based cofounders of the Innovative Medicines Initiative’s New Drugs for Bad Bugs program bringing Industry and Academic collaborators together on a range of antibiotic discovery and development projects.

Next Post